| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Referees
|
|
|
2017
|
|
4 |
p. 231-232
|
artikel
|
| 2 |
Acknowledgement to Referees
|
|
|
2018
|
|
4 |
p. 355-356
|
artikel
|
| 3 |
Acknowledgement to Referees
|
|
|
|
|
4 |
p. 429-431
|
artikel
|
| 4 |
Acknowledgement to Referees
|
|
|
|
|
4 |
p. 555-556
|
artikel
|
| 5 |
A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers
|
Foroutan, Naghmeh
|
|
|
|
4 |
p. 437-451
|
artikel
|
| 6 |
A Corticosteroid-Eluting Sinus Implant Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis: A UK-Based Cost-Effectiveness Analysis
|
Javanbakht, Mehdi
|
|
|
|
4 |
p. 679-686
|
artikel
|
| 7 |
A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa
|
Makhele, Letlhogonolo
|
|
|
|
4 |
p. 631-641
|
artikel
|
| 8 |
A Model-Based Economic Evaluation of Cladribine Versus Alemtuzumab, Ocrelizumab and Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Chile
|
Espinoza, Manuel Antonio
|
|
|
|
4 |
p. 635-647
|
artikel
|
| 9 |
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study
|
de Andrés-Nogales, Fernando
|
|
|
|
4 |
p. 615-624
|
artikel
|
| 10 |
Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017
|
Usher, Cara
|
|
|
|
4 |
p. 583-589
|
artikel
|
| 11 |
An Exploratory Study: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D for Long-Term Publicly Waitlisted Bariatric Surgery Patients Before and 3 Months After Bariatric Surgery
|
Campbell, Julie A.
|
|
2017
|
|
4 |
p. 443-458
|
artikel
|
| 12 |
Application of a Mapping Function to Estimate Utilities for Ragweed Allergy Immunotherapy Trials
|
Dick, Katherine
|
|
|
|
4 |
p. 649-655
|
artikel
|
| 13 |
A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R
|
Lin, Yi-Shu
|
|
|
|
4 |
p. 507-523
|
artikel
|
| 14 |
A Systematic Review of the Health Economics of Pompe Disease
|
Schoser, Benedikt
|
|
|
|
4 |
p. 479-493
|
artikel
|
| 15 |
Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
|
Stainthorpe, Angela
|
|
|
|
4 |
p. 563-574
|
artikel
|
| 16 |
Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
|
Fleeman, Nigel
|
|
|
|
4 |
p. 453-461
|
artikel
|
| 17 |
Check Your Checklist: The Danger of Over- and Underestimating the Quality of Economic Evaluations
|
Frederix, Geert W. J.
|
|
|
|
4 |
p. 433-435
|
artikel
|
| 18 |
Choosing Between Unicompartmental and Total Knee Replacement: What Can Economic Evaluations Tell Us? A Systematic Review
|
Burn, Edward
|
|
2017
|
|
4 |
p. 241-253
|
artikel
|
| 19 |
Correction to: A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa
|
Makhele, Letlhogonolo
|
|
|
|
4 |
p. 647
|
artikel
|
| 20 |
Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries
|
Fontrier, Anna-Maria
|
|
|
|
4 |
p. 629
|
artikel
|
| 21 |
Cost Analysis of Adjuvant Whole-Brain Radiotherapy Treatment Versus No Whole-Brain Radiotherapy After Stereotactic Radiosurgery and/or Surgery Among Adults with One to Three Melanoma Brain Metastases: Results from a Randomized Trial
|
Tran, Anh Dam
|
|
|
|
4 |
p. 587-594
|
artikel
|
| 22 |
Cost Analysis of the Automated Examination of Urine with the Sysmex UN-Series™ in a Spanish Population
|
Herráez Carrera, Óscar
|
|
|
|
4 |
p. 605-613
|
artikel
|
| 23 |
Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews
|
Monga, Neerav
|
|
|
|
4 |
p. 575-591
|
artikel
|
| 24 |
Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer in the UK
|
Telford, Claire
|
|
|
|
4 |
p. 559-570
|
artikel
|
| 25 |
Cost-Effectiveness Analysis of Intravascular Targeted Temperature Management after Cardiac Arrest in England
|
Javanbakht, Mehdi
|
|
|
|
4 |
p. 549-562
|
artikel
|
| 26 |
Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)
|
Garay, Osvaldo Ulises
|
|
|
|
4 |
p. 505-515
|
artikel
|
| 27 |
Cost-Effectiveness Analysis of rFVIIIFc Versus Contemporary rFVIII Treatments for Patients with Severe Hemophilia A Without Inhibitors in the United States
|
Bullement, Ash
|
|
|
|
4 |
p. 625-633
|
artikel
|
| 28 |
Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK
|
Schweikert, Bernd
|
|
|
|
4 |
p. 635-648
|
artikel
|
| 29 |
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
|
Djatche, Laurence M.
|
|
2018
|
|
4 |
p. 371-380
|
artikel
|
| 30 |
Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France
|
Caillon, Megane
|
|
|
|
4 |
p. 639-653
|
artikel
|
| 31 |
Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK
|
Russell-Smith, T. Alexander
|
|
|
|
4 |
p. 677-691
|
artikel
|
| 32 |
Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland
|
Çakar, Esra
|
|
|
|
4 |
p. 567-577
|
artikel
|
| 33 |
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
|
Johansen, Pierre
|
|
|
|
4 |
p. 537-550
|
artikel
|
| 34 |
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare Sector Setting
|
Raunbak, Sabine Michelsen
|
|
|
|
4 |
p. 483-494
|
artikel
|
| 35 |
Cost-Effectiveness of Peer-Educator–Delivered Lifestyle Modification for Type 2 Diabetes Prevention in a Young Healthy Population in Sri Lanka: A Trial-Based Economic Evaluation and Economic Model
|
Shearer, James
|
|
|
|
4 |
p. 693-700
|
artikel
|
| 36 |
Cost-Effectiveness of Semaglutide vs. Empagliflozin, Canagliflozin, and Sitagliptin for Treatment of Patients with Type 2 Diabetes in Denmark: A Decision-Analytic Modelling Study
|
Pulleyblank, Ryan
|
|
|
|
4 |
p. 579-591
|
artikel
|
| 37 |
Cost Effectiveness of Strategies for Caring for Critically Ill Patients with COVID-19 in Tanzania
|
Shah, Hiral Anil
|
|
|
|
4 |
p. 537-552
|
artikel
|
| 38 |
Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada
|
Fenu, Elisabetta
|
|
|
|
4 |
p. 519-537
|
artikel
|
| 39 |
Cost-Minimization Analysis of Pembrolizumab Monotherapy Versus Nivolumab in Combination with Ipilimumab as First-Line Treatment for Metastatic PD-L1-Positive Non-small Cell Lung Cancer: A US Payer Perspective
|
Qiao, Nan
|
|
|
|
4 |
p. 765-778
|
artikel
|
| 40 |
Costs and Effects of Implementing Digital Tomosynthesis in a Population-Based Breast Cancer Screening Program: Predictions Using Results from the To-Be Trial in Norway
|
Moger, Tron Anders
|
|
|
|
4 |
p. 495-507
|
artikel
|
| 41 |
Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia
|
Belay, Yared Belete
|
|
|
|
4 |
p. 655-664
|
artikel
|
| 42 |
Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review
|
Zelei, Tamás
|
|
|
|
4 |
p. 605-612
|
artikel
|
| 43 |
Dealing with Time Estimates in Hospital Cost Accounting: Integrating Fuzzy Logic into Time-Driven Activity-Based Costing
|
Koster, Fiona
|
|
|
|
4 |
p. 593-603
|
artikel
|
| 44 |
Development of a Procedure for the Government Provision of Bone-Anchored Prosthesis Using Osseointegration in Australia
|
Frossard, Laurent
|
|
2017
|
|
4 |
p. 301-314
|
artikel
|
| 45 |
Development of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ): A New Patient-Reported Outcome (PRO) Instrument
|
Reaney, Matthew
|
|
|
|
4 |
p. 563-574
|
artikel
|
| 46 |
Differences in Breast Cancer Costs by Cancer Stage and Biomarker Subtype in New Zealand
|
Lao, Chunhuan
|
|
|
|
4 |
p. 539-548
|
artikel
|
| 47 |
Direct and Indirect Costs of Non-surgical Treatment for Acute Tonsillitis in Children in Southeast Nigeria
|
Ughasoro, Maduka Donatus
|
|
|
|
4 |
p. 755-764
|
artikel
|
| 48 |
Direct Medical Costs of Four Vaccine-Preventable Infectious Diseases in Older Adults in Spain
|
Gil de Miguel, Ángel
|
|
|
|
4 |
p. 509-518
|
artikel
|
| 49 |
Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review
|
Pergola, Pablo E.
|
|
|
|
4 |
p. 463-478
|
artikel
|
| 50 |
Economic Burden of the Out-of-Pocket Expenses for People with Multiple Sclerosis in France
|
Heinzlef, Olivier
|
|
|
|
4 |
p. 593-603
|
artikel
|
| 51 |
Economic Evaluation of Fulvestrant 500 mg Compared to Generic Aromatase Inhibitors in Patients with Advanced Breast Cancer in Sweden
|
Sabale, Ugne
|
|
2017
|
|
4 |
p. 279-290
|
artikel
|
| 52 |
Economic Evaluation of Transperineal versus Transrectal Devices for Local Anaesthetic Prostate Biopsies
|
Wilson, Edward C. F.
|
|
|
|
4 |
p. 737-753
|
artikel
|
| 53 |
Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis
|
Afentou, Nafsika
|
|
|
|
4 |
p. 605-617
|
artikel
|
| 54 |
Effect of Perioperative Oral Vitamin C Supplementation on In-Hospital Postoperative Medication Costs for Cardiac Surgery Patients: A Prospective, Single-Centre, Randomised Clinical Trial
|
Heerman, Jan
|
|
|
|
4 |
p. 655-663
|
artikel
|
| 55 |
Eliciting the Monetary Value of a Quality-Adjusted Life Year in a Greek Outpatient Department in Times of Economic Austerity
|
Mavrodi, A.
|
|
2017
|
|
4 |
p. 291-300
|
artikel
|
| 56 |
Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis
|
Bazarbashi, Shouki
|
|
|
|
4 |
p. 625-633
|
artikel
|
| 57 |
Estimation of Health-Related Utilities for 177Lu-DOTATATE in GEP-NET Patients Using Utilities Mapped from EORTC QLQ-C30 to EQ-5D-3L and QLU-C10D Utilities
|
Soare, Ioana-Alexandra
|
|
|
|
4 |
p. 715-725
|
artikel
|
| 58 |
Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
|
Kruger, Eliza
|
|
|
|
4 |
p. 627-638
|
artikel
|
| 59 |
Estimation of the Incremental Cumulative Cost of HIV Compared with a Non-HIV Population
|
Cohen, Joshua P.
|
|
|
|
4 |
p. 687-696
|
artikel
|
| 60 |
Evidence-Based Medicine and Healthcare Quality in the Context of Information Failure: The Case of the UK Fertility Sector
|
Zhu, Minyan
|
|
|
|
4 |
p. 561-576
|
artikel
|
| 61 |
Feasibility of Deriving Health State Utilities in Mycosis Fungoides Cutaneous T-Cell Lymphoma Using Mapping Algorithms
|
Meregaglia, Michela
|
|
|
|
4 |
p. 595-603
|
artikel
|
| 62 |
Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls
|
Kingdon, Caroline C.
|
|
2018
|
|
4 |
p. 381-392
|
artikel
|
| 63 |
gammaCore for Cluster Headaches: A NICE Medical Technologies Guidance
|
O’Connell, Susan
|
|
|
|
4 |
p. 577-586
|
artikel
|
| 64 |
Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014
|
Nathanson, David
|
|
2017
|
|
4 |
p. 393-402
|
artikel
|
| 65 |
Healthcare Payer Perspectives on the Assessment and Pricing of Oncology Multi-Indication Products: Evidence from Nine OECD Countries
|
Mills, Mackenzie
|
|
|
|
4 |
p. 553-565
|
artikel
|
| 66 |
Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
|
Kocaata, Zeki
|
|
|
|
4 |
p. 619-628
|
artikel
|
| 67 |
Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis
|
Vanderpoel, Julie
|
|
|
|
4 |
p. 617-626
|
artikel
|
| 68 |
Hospital Costs of Extracorporeal Membrane Oxygenation in Adults: A Systematic Review
|
Oude Lansink-Hartgring, Annemieke
|
|
|
|
4 |
p. 613-623
|
artikel
|
| 69 |
How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton
|
Roope, Laurence S. J.
|
|
|
|
4 |
p. 557-561
|
artikel
|
| 70 |
Impact of Including Carer Information in Time Trade-Off Tasks: Results from a Pilot Study
|
Mott, David J.
|
|
|
|
4 |
p. 665-675
|
artikel
|
| 71 |
Including Future Consumption and Production in Economic Evaluation of Interventions that Save Life-Years: Commentary
|
Nord, Erik
|
|
2018
|
|
4 |
p. 357-358
|
artikel
|
| 72 |
Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses
|
Nymark, Liv Solvår
|
|
|
|
4 |
p. 587-603
|
artikel
|
| 73 |
Indonesian Social Health Insurance Sample Data are Now Available and Accessible for Research
|
Fuad, Anis
|
|
|
|
4 |
p. 643-645
|
artikel
|
| 74 |
Is Protocolised Weaning that Includes Early Extubation Onto Non-Invasive Ventilation More Cost Effective Than Protocolised Weaning Without Non-Invasive Ventilation? Findings from the Breathe Study
|
Khan, Iftekhar
|
|
|
|
4 |
p. 697-710
|
artikel
|
| 75 |
Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER+ Breast Cancer: A Systematic Review
|
Xiao, Hong
|
|
2018
|
|
4 |
p. 359-369
|
artikel
|
| 76 |
Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial
|
Reaney, Matthew
|
|
|
|
4 |
p. 575-586
|
artikel
|
| 77 |
Long-Term Inpatient Hospital Utilisation and Costs (2007–2008 to 2015–2016) for Publicly Waitlisted Bariatric Surgery Patients in an Australian Public Hospital System Based on Australia’s Activity-Based Funding Model
|
Campbell, Julie A.
|
|
|
|
4 |
p. 599-618
|
artikel
|
| 78 |
Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis
|
Baldwin, Zachary
|
|
|
|
4 |
p. 469-481
|
artikel
|
| 79 |
Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR)
|
Masucci, Lisa
|
|
2017
|
|
4 |
p. 255-263
|
artikel
|
| 80 |
National Health Insurance Databases in Indonesia, Vietnam and the Philippines
|
Ng, Junice Yi Siu
|
|
|
|
4 |
p. 517-526
|
artikel
|
| 81 |
Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making
|
Gordon, Jason
|
|
|
|
4 |
p. 701-713
|
artikel
|
| 82 |
Observational Cost-Effectiveness Analysis Using Routine Data: Admission and Discharge Care Bundles for Patients with Chronic Obstructive Pulmonary Disease
|
Dixon, Padraig
|
|
|
|
4 |
p. 657-667
|
artikel
|
| 83 |
Out-of-Pocket Household Expenditures on Medical Injections in Cambodia
|
Ozawa, Sachiko
|
|
2018
|
|
4 |
p. 415-421
|
artikel
|
| 84 |
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
|
Bresnahan, Rebecca
|
|
|
|
4 |
p. 525-536
|
artikel
|
| 85 |
Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial
|
Pirhonen, Laura
|
|
|
|
4 |
p. 495-504
|
artikel
|
| 86 |
Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective
|
Wahono, Cesarius Singgih
|
|
|
|
4 |
p. 605-615
|
artikel
|
| 87 |
Smart Pump–Electronic Health Record (EHR) Interoperability with Auto-Documentation is Associated with Increased Submission of Infusion-Therapy Billing Claims at a Community Hospital
|
Suess, Tina M.
|
|
|
|
4 |
p. 619-629
|
artikel
|
| 88 |
Smoking Cessation Pharmacotherapy Utilization and Costs to a Medicaid Managed Care Plan
|
Corelli, Robin L.
|
|
|
|
4 |
p. 649-653
|
artikel
|
| 89 |
Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values
|
Round, Jeff
|
|
2017
|
|
4 |
p. 233-239
|
artikel
|
| 90 |
Systematic Review and Cost-Consequence Analysis of Ambu aScope 5 Broncho Compared with Reusable Flexible Bronchoscopes: Insights from Two US University Hospitals and an Academic Institution
|
Kristensen, Anders E.
|
|
|
|
4 |
p. 665-678
|
artikel
|
| 91 |
The Budget Impact of Introducing Tildrakizumab to a United States Health Plan for Managing Moderate-to-Severe Plaque Psoriasis
|
Carrico, Justin
|
|
|
|
4 |
p. 669-677
|
artikel
|
| 92 |
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study
|
Jommi, Claudio
|
|
2017
|
|
4 |
p. 459-467
|
artikel
|
| 93 |
The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the US
|
Chatterjee, Satabdi
|
|
|
|
4 |
p. 727-736
|
artikel
|
| 94 |
The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
|
Akpinar, Ilke
|
|
|
|
4 |
p. 591-597
|
artikel
|
| 95 |
The Healthcare Cost Burden of Acute Myocardial Infarction in Alberta, Canada
|
Tran, Dat T.
|
|
2017
|
|
4 |
p. 433-442
|
artikel
|
| 96 |
Use of Initial Noninvasive Cardiac Testing and Association with Downstream Healthcare Resource: A Retrospective Review of Resources Used Across a 12-Month Window for Probable Type I Myocardial Infarction Patients
|
Villines, Dana
|
|
|
|
4 |
p. 527-535
|
artikel
|
| 97 |
Using a Discrete-Choice Experiment to Estimate the Preferences of Clinical Practitioners for a Novel Non-invasive Device for Diagnosis of Peripheral Arterial Disease in Primary Care
|
Oluboyede, Yemi
|
|
|
|
4 |
p. 571-581
|
artikel
|
| 98 |
Using Time Trade-Off Methods to Elicit Short-Term Utilities Associated with Treatments for Bulbar Urethral Stricture
|
Shen, Jing
|
|
|
|
4 |
p. 551-558
|
artikel
|
| 99 |
Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and Implications
|
Jakupi, Arianit
|
|
2018
|
|
4 |
p. 423-432
|
artikel
|
| 100 |
Utilization of Intergovernmental Funds to Implement Maternal and Child Health Plans of a Multi-Strategy Community Intervention in Haryana, North India: A Retrospective Assessment
|
Gupta, Madhu
|
|
2017
|
|
4 |
p. 265-278
|
artikel
|
| 101 |
Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease
|
Lomas, James
|
|
2018
|
|
4 |
p. 403-413
|
artikel
|
Tijdschrift beschrijving